Sci Simple

New Science Research Articles Everyday

# Health Sciences # Rheumatology

Neutrophils: The Double-Edged Sword in Rheumatoid Arthritis

Understanding the complex role of neutrophils in rheumatoid arthritis inflammation.

Michele Fresneda Alarcon, Genna Ali Abdullah, John Alexander Beggs, Isobel Kynoch, Andrew Sellin, Andrew Cross, Sam Haldenby, Philipp Antczak, Eva Caamaño Gutiérrez, Helen Louise Wright

― 5 min read


Neutrophils in RA: Neutrophils in RA: Friends or Foes? rheumatoid arthritis inflammation. Exploring neutrophils' role in
Table of Contents

Rheumatoid Arthritis (RA) is a long-lasting illness that mainly affects the joints. It happens when the body's immune system mistakenly attacks its own joint tissues, causing pain, swelling, and possible joint damage. Although the exact reasons why RA occurs are still unclear, researchers believe it involves a mix of genetics (what we're born with), environmental factors (like where we live and what we do), and immune system responses.

The Role of Neutrophils

One of the key players in rheumatoid arthritis is a type of white blood cell known as neutrophils. Neutrophils are the body's first line of defense against infections. They arrive quickly at injured or infected areas and work to eliminate harmful invaders by engulfing them or releasing substances that destroy them. When everything is functioning well, neutrophils help us heal and recover.

However, things can go awry when it comes to autoimmune diseases like rheumatoid arthritis. Instead of helping, these overly eager neutrophils can cause more harm than good. In RA, neutrophils become excessively activated and gather in the joints where they release a cocktail of substances that continue the inflammation process, leading to further damage.

Neutrophil Activity in RA

In people with rheumatoid arthritis, neutrophils are not just arriving at the scene; they are overdoing it. These cells accumulate in the joint fluid and tissues, surviving longer than they should because their process of death (known as apoptosis) is reduced. This prolonged presence leads to more inflammation and tissue damage.

Activated neutrophils in the joints of RA patients release various inflammatory substances, including chemicals like cytokines and reactive oxygen species. These substances can contribute to pain and damage to the cartilage and bone, which can worsen the overall condition.

What Researchers Are Discovering

Scientists are taking a closer look at the gene activity in neutrophils from patients with RA, especially during flare-ups. Research has shown that neutrophils from RA patients display unique Gene Expressions compared to those from healthy individuals. This means they are "talking" differently at a cellular level.

For example, certain genes that help neutrophils respond to inflammation and move to the right locations are more active in RA neutrophils. Researchers have identified that the activation of genes related to producing reactive oxygen species (the body's way of fighting off threats) is often heightened in these neutrophils.

Neutrophil Extracellular Traps (NETS)

Another interesting aspect of neutrophils is their ability to form something called neutrophil extracellular traps, or NETs for short. Imagine these traps as sticky webs that neutrophils can deploy to catch and kill bacteria. However, in the context of RA, these traps can also expose proteins that confuse the immune system, leading to the production of unwanted antibodies. This confusion can further fuel the autoimmune response.

The Role of NETs in Autoimmunity

In patients with RA, NETs tend to be more abundant. Their presence can lead to higher levels of antibodies that mistakenly target the body’s own tissues. It’s like your immune system is throwing a surprise party for itself, but instead of cake, it’s serving up inflammation and pain.

Studying Neutrophils in RA

To understand the behaviors and gene expressions of neutrophils in RA better, researchers conduct various types of studies. They isolate neutrophils from blood samples taken from patients and healthy volunteers. From there, scientists can analyze how these cells behave, what genes are active, and how they interact with other immune cells.

Ethical Considerations and Patient Consent

Before conducting research, it’s crucial to obtain proper permissions from participants. Researchers ensure that all participants are informed and consenting, following strict ethical guidelines. This respects the rights of individuals while allowing scientists to pursue important discoveries.

Gene Expression Patterns

One of the significant findings is that neutrophils from patients with early or severe RA show similar gene expression patterns. By looking at these gene patterns, researchers can learn more about how RA develops and progresses.

In severe cases of RA, certain genes are commonly turned on, which can indicate that neutrophils are responding intensely to the inflammatory environment. This constant activation becomes a troublesome cycle that maintains inflammation and joint damage.

MicroRNAs: The Tiny Regulators

On top of the genes themselves, there are tiny molecules called microRNAs that help control the activity of these genes. Researchers have found that specific microRNAs are linked to the heightened immune responses in RA neutrophils. These little molecules might act like volume controls, turning the expression of certain genes up or down.

Studying microRNAs could open new avenues for treatment, providing potential targets for therapies aimed at reducing inflammation and controlling joint damage.

The Impact of External Factors

Researchers also consider how outside factors like diet, stress, and infections can influence the behavior of neutrophils in RA. The immune system is complex, and external stressors can sometimes trigger or worsen autoimmune responses.

Current and Future Research Directions

The ongoing investigations into the role of neutrophils in RA are promising. Scientists are hoping to find targeted therapies that can modulate the activity of these cells, aiming to reduce inflammation and improve patient outcomes.

Understanding how neutrophils behave, the genes they express, and how microRNAs influence these processes will be pivotal in developing new treatments.

Conclusion

Rheumatoid arthritis is a complex condition marked by persistent inflammation and joint damage. Neutrophils play a central role in this process, as their over-activation can exacerbate the situation instead of resolving it. With ongoing research, there's hope for new treatments that can help manage this condition more effectively.

So, the next time you hear about neutrophils, remember these little warriors are not just fighting off infections but also engaging in a complex dance that can lead to both healing and, unfortunately, harm in conditions like rheumatoid arthritis.

Original Source

Title: Complexity of the neutrophil transcriptome in early and severe rheumatoid arthritis. A role for microRNAs?

Abstract: Neutrophils are innate immune cells that drive the progression of rheumatoid arthritis (RA) through the release of reactive oxygen species (ROS), neutrophil extracellular traps (NETs) and proteases that damage host tissues. Neutrophil activation is regulated, in part, by dynamic changes in gene expression. In this study we have used RNAseq to measure the transcriptomes of neutrophils from people with severe, methotrexate-refractory RA and healthy controls. We identified a dynamic gene expression profile in people with severe RA. This is dominated by a type-I interferon-induced gene expression signature as well as activation of genes regulating neutrophil degranulation, NET production, response to ROS and oxidative stress. Whilst we did not detect significantly elevated levels of interferon-alpha in RA blood sera, we identified increased expression in RA neutrophils of miR-96-5p and miR-183-5p which regulate activation of the interferon pathway as members of the miR-183C cluster. We also detected significantly elevated NET debris in RA blood sera (p

Authors: Michele Fresneda Alarcon, Genna Ali Abdullah, John Alexander Beggs, Isobel Kynoch, Andrew Sellin, Andrew Cross, Sam Haldenby, Philipp Antczak, Eva Caamaño Gutiérrez, Helen Louise Wright

Last Update: 2024-12-16 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.12.12.24318900

Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.12.24318900.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles